| 000 | 01240nam a2200133Ia 4500 | ||
|---|---|---|---|
| 008 | 220620s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a9783040000000 | ||
| 245 | 0 |
_aMultiple Sclerosis _bDiagnosis and Treatment |
|
| 546 | _aEnglish[eng] | ||
| 650 | _amultiple sclerosis||genetics||disease modifying therapies||generic medicines||association study||reactive oxygen species||NADPH oxidase||CYBB||autoimmunity||axon||cortex||demyelination||mitochondria||myelin||neurodegeneration||oligodendrocyte||progressive multiple sclerosis||daclizumab||relapsing multiple sclerosis||CD25||innate immune system||interleukin-2||drug reaction with eosinophilia systemic symptoms||DRESS||monoclonal antibodies||anti-CD20||Ocrevus||Rituxan||Tysabri||clinical trial||disease modifying therapy||demyelinating diseases||cognitive impairment||cognitive dysfunction||stem cells||autologous hematopoietic||mesenchymal||neuronal||induced pluripotent||human embryonic||pregnancy||post-partum||treatment||neuromyelitis optica spectrum disorders||anti-MOG syndrome||aquaporin 4-IgG||myelin oligodendrocyte glycoprotein||remyelination||outcome measures||biomarkers | ||
| 700 | _aRivera, VÃctor M. | ||
| 856 | _uhttps://mdpi.com/books/pdfview/book/4935 | ||
| 942 | _cEB | ||
| 999 |
_c30442 _d30442 |
||